Echo Therapeutics PE Ratio 2010-2016 | ECTE
Current and historical p/e ratio for Echo Therapeutics (ECTE) from 2010 to 2016. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Echo Therapeutics PE ratio as of July 24, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Echo Therapeutics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2021-09-08 | 0.00 | 0.00 | |
| 2016-09-30 | 0.38 | $-1.28 | 0.00 |
| 2016-06-30 | 1.30 | $-1.33 | 0.00 |
| 2016-03-31 | 1.31 | $-1.48 | 0.00 |
| 2015-12-31 | 1.42 | $-1.97 | 0.00 |
| 2015-09-30 | 1.55 | $-1.89 | 0.00 |
| 2015-06-30 | 1.70 | $-2.16 | 0.00 |
| 2015-03-31 | 2.13 | $-1.50 | 0.00 |
| 2014-12-31 | 1.35 | $-1.01 | 0.00 |
| 2014-09-30 | 0.84 | $-1.33 | 0.00 |
| 2014-06-30 | 2.26 | $-1.39 | 0.00 |
| 2014-03-31 | 3.00 | $-1.59 | 0.00 |
| 2013-12-31 | 3.14 | $-2.66 | 0.00 |
| 2013-09-30 | 2.76 | $-2.70 | 0.00 |
| 2013-06-30 | 2.49 | $-3.31 | 0.00 |
| 2013-03-31 | 7.90 | $-3.60 | 0.00 |
| 2012-12-31 | 10.40 | $-3.10 | 0.00 |
| 2012-09-30 | 15.70 | $-4.60 | 0.00 |
| 2012-06-30 | 16.20 | $-3.90 | 0.00 |
| 2012-03-31 | 20.21 | $-3.70 | 0.00 |
| 2011-12-31 | 22.60 | $-4.90 | 0.00 |
| 2011-09-30 | 29.01 | $-3.40 | 0.00 |
| 2011-06-30 | 40.60 | $-3.20 | 0.00 |
| 2011-03-31 | 40.00 | $-2.80 | 0.00 |
| 2010-12-31 | 16.00 | $-1.50 | 0.00 |
| 2010-09-30 | 10.00 | $-1.60 | 0.00 |
| 2010-06-30 | 12.50 | $-1.90 | 0.00 |
| 2010-03-31 | 15.00 | $-6.30 | 0.00 |
| 2009-12-31 | 17.00 | $-6.30 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Echo Therapeutics, Inc., a medical device and specialty pharmaceutical company, develops a non-invasive and wireless transdermal continuous glucose monitoring system for people with diabetes and for use in hospital critical care units in the United States. Its Symphony transdermal continuous glucose monitoring System is a non-invasive, wireless, designed to provide reliable, on-demand blood glucose data conveniently, continuously and cost-effectively. The company is based in Franklin, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $179.908B | 74.58 |
| Thermo Fisher Scientific (TMO) | United States | $176.180B | 21.32 |
| Alcon (ALC) | Switzerland | $45.487B | 30.74 |
| Edwards Lifesciences (EW) | United States | $45.115B | 29.58 |
| IDEXX Laboratories (IDXX) | United States | $43.483B | 49.97 |
| DexCom (DXCM) | United States | $33.890B | 52.38 |
| IQVIA Holdings (IQV) | United States | $33.021B | 18.66 |
| Mettler-Toledo (MTD) | United States | $26.128B | 31.07 |
| STERIS (STE) | Ireland | $22.180B | 24.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.745B | 0.00 |
| Waters (WAT) | United States | $17.593B | 24.82 |
| Hologic (HOLX) | United States | $14.697B | 15.97 |
| Sysmex ADR (SSMXY) | Japan | $10.821B | 30.70 |
| Penumbra (PEN) | United States | $9.038B | 70.94 |
| Masimo (MASI) | United States | $8.946B | 33.00 |
| Globus Medical (GMED) | United States | $7.316B | 17.43 |
| Glaukos (GKOS) | United States | $5.485B | 0.00 |
| Teleflex (TFX) | United States | $5.181B | 8.55 |
| Integer Holdings (ITGR) | United States | $4.039B | 21.17 |
| TransMedics (TMDX) | United States | $3.720B | 80.86 |
| PROCEPT BioRobotics (PRCT) | United States | $3.323B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.406B | 14.32 |
| Nihon Kohden (NHNKY) | Japan | $2.154B | 24.71 |
| Elekta AB (EKTAY) | Sweden | $1.952B | 17.55 |
| Veracyte (VCYT) | United States | $1.896B | 26.60 |
| Alphatec Holdings (ATEC) | United States | $1.583B | 0.00 |
| Artivion (AORT) | United States | $1.334B | 124.96 |
| OPKO Health (OPK) | United States | $1.134B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.076B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.995B | 5.29 |
| SiBone (SIBN) | United States | $0.757B | 0.00 |
| IRadimed (IRMD) | United States | $0.725B | 36.77 |
| Beta Bionics (BBNX) | United States | $0.640B | 0.00 |
| AxoGen (AXGN) | United States | $0.613B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.575B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| Semler Scientific (SMLR) | United States | $0.542B | 11.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.507B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.451B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.411B | 9.54 |
| Delcath Systems (DCTH) | United States | $0.404B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.382B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.324B | 0.00 |
| RxSight (RXST) | United States | $0.321B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Neuronetics (STIM) | United States | $0.294B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.244B | 14.76 |
| CVRx (CVRX) | United States | $0.224B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.205B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.195B | 0.00 |
| Inogen (INGN) | United States | $0.181B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.151B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.119B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.103B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Hyperfine (HYPR) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.20 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.072B | 0.00 |
| Spectral AI (MDAI) | United States | $0.063B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.54 |